Balaxi Pharmaceuticals Ltd

Balaxi Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaxi Pharmaceuticals Ltd

₹ 30.1 -8.96%
12 Dec - close price
balaxiventures.in NSE: BALAXI
About

Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. [1]

Key Points

Product Portfolio
The company is a branded IPR-based pharmaceutical player focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs across multiple therapeutic segments. As of 9M FY25, it has a portfolio of 897 registered products across 7 countries in Africa and Latin America serving through 38 warehouses. [1] [2] [3]

Website NSE
  • Market Cap ₹ 166 Cr.
  • Current Price ₹ 30.1
  • High / Low ₹ 84.0 / 29.6
  • Stock P/E 41.4
  • Book Value ₹ 23.8
  • Dividend Yield 0.00 %
  • ROCE 5.06 %
  • ROE 2.89 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 5.97% over past five years.
  • Company has a low return on equity of 7.67% over last 3 years.
  • Earnings include an other income of Rs.7.91 Cr.
  • Company has high debtors of 538 days.
  • Promoter holding has decreased over last 3 years: -6.87%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
28.26 23.07 30.35 25.04 16.55 12.70 15.90 19.03 21.16 11.16 9.65 16.71 19.31
24.73 19.50 24.94 21.27 15.64 12.42 15.70 17.53 19.68 11.06 10.31 16.17 18.53
Operating Profit 3.53 3.57 5.41 3.77 0.91 0.28 0.20 1.50 1.48 0.10 -0.66 0.54 0.78
OPM % 12.49% 15.47% 17.83% 15.06% 5.50% 2.20% 1.26% 7.88% 6.99% 0.90% -6.84% 3.23% 4.04%
2.50 1.34 0.18 0.13 1.15 1.03 0.16 0.85 1.29 2.92 0.32 0.46 4.21
Interest 0.02 0.01 0.23 0.26 0.36 0.41 0.51 0.35 0.45 0.57 0.69 0.63 0.62
Depreciation 0.08 0.08 0.27 0.13 0.13 0.13 0.12 0.12 0.12 0.11 0.11 0.11 0.12
Profit before tax 5.93 4.82 5.09 3.51 1.57 0.77 -0.27 1.88 2.20 2.34 -1.14 0.26 4.25
Tax % 32.88% 26.56% 22.59% 27.35% 24.84% 36.36% 114.81% 27.13% 24.55% 25.21% 3.51% 23.08% 22.82%
3.98 3.53 3.94 2.55 1.18 0.49 -0.58 1.38 1.66 1.74 -1.18 0.19 3.26
EPS in Rs 0.80 0.70 0.77 0.50 0.23 0.10 -0.11 0.25 0.30 0.32 -0.21 0.03 0.59
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0.14 0.12 0.05 0.00 0.00 13.60 45.63 86.87 101.29 108.14 70.20 60.99 56.83
0.03 0.08 0.11 0.13 0.77 12.05 36.98 67.85 83.99 91.26 64.78 58.38 56.07
Operating Profit 0.11 0.04 -0.06 -0.13 -0.77 1.55 8.65 19.02 17.30 16.88 5.42 2.61 0.76
OPM % 78.57% 33.33% -120.00% 11.40% 18.96% 21.89% 17.08% 15.61% 7.72% 4.28% 1.34%
0.05 0.12 0.00 0.00 0.00 0.89 0.59 1.81 2.75 6.60 2.33 5.37 7.91
Interest 0.01 0.01 0.05 0.04 0.00 0.00 0.05 0.15 0.10 0.51 1.66 2.24 2.51
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.09 0.25 0.52 0.51 0.46 0.45
Profit before tax 0.15 0.15 -0.11 -0.17 -0.77 2.44 9.18 20.59 19.70 22.45 5.58 5.28 5.71
Tax % 26.67% 26.67% -36.36% 0.00% 0.00% 19.26% 29.30% 26.52% 25.53% 27.75% 34.59% 31.82%
0.11 0.10 -0.08 -0.17 -0.77 1.97 6.50 15.13 14.67 16.22 3.65 3.60 4.01
EPS in Rs 0.31 0.07 -0.05 -0.11 -0.51 1.30 1.30 3.03 2.93 3.19 0.67 0.65 0.73
Dividend Payout % 63.64% 91.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.41% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 86%
5 Years: 6%
3 Years: -16%
TTM: -17%
Compounded Profit Growth
10 Years: 43%
5 Years: -11%
3 Years: -37%
TTM: 36%
Stock Price CAGR
10 Years: 17%
5 Years: -25%
3 Years: -38%
1 Year: -64%
Return on Equity
10 Years: 15%
5 Years: 14%
3 Years: 8%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.70 3.04 3.04 3.04 3.04 3.04 10.00 10.00 10.00 10.18 10.90 11.04 11.04
Reserves 0.08 0.18 0.11 -0.72 -1.49 0.48 18.11 33.25 47.91 81.93 110.65 116.81 120.27
0.18 0.00 0.20 0.00 0.00 0.00 0.00 3.51 1.93 12.44 15.70 32.18 35.16
0.24 0.46 0.22 0.05 0.13 2.59 9.79 22.16 22.07 25.17 17.12 14.41 23.44
Total Liabilities 1.20 3.68 3.57 2.37 1.68 6.11 37.90 68.92 81.91 129.72 154.37 174.44 189.91
0.00 0.00 0.00 0.00 0.01 0.01 0.19 0.69 2.20 7.89 7.10 6.67 6.48
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57 2.83 2.31 22.07 34.28
Investments 0.19 3.42 3.29 0.00 0.00 0.00 0.10 19.54 19.61 19.54 19.88 25.07 53.20
1.01 0.26 0.28 2.37 1.67 6.10 37.61 48.69 59.53 99.46 125.08 120.63 95.95
Total Assets 1.20 3.68 3.57 2.37 1.68 6.11 37.90 68.92 81.91 129.72 154.37 174.44 189.91

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.24 0.21 -0.03 -0.13 -0.68 -1.51 -14.37 13.46 8.89 -7.07 -1.83 -7.60
0.32 -3.11 0.13 2.67 -0.01 -0.01 -0.28 -20.03 -6.87 -2.29 0.46 -24.98
-0.07 2.38 -0.11 -0.24 0.00 0.00 18.10 3.49 -1.64 26.39 27.55 17.21
Net Cash Flow 0.01 -0.52 -0.02 2.30 -0.69 -1.51 3.44 -3.08 0.38 17.04 26.19 -15.37

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 756.07 30.42 0.00 146.81 249.73 202.23 187.78 264.25 399.11 538.13
Inventory Days 9.23 0.12 0.00 6.62 5.43 0.00
Days Payable 81.27 95.96 76.73 80.38
Cash Conversion Cycle 756.07 30.42 0.00 146.81 177.69 106.38 187.78 194.14 324.16 538.13
Working Capital Days 104.29 -669.17 -1,387.00 82.12 186.70 94.62 105.47 156.31 253.73 282.17
ROCE % 17.11% 7.66% -1.83% -4.59% -39.79% 96.25% 58.36% 55.40% 37.15% 27.93% 6.05% 5.06%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
72.69% 71.57% 71.22% 71.22% 71.22% 66.86% 65.99% 65.99% 65.99% 65.99% 65.99% 65.99%
18.95% 18.66% 18.57% 18.57% 18.57% 17.21% 16.88% 16.48% 16.48% 16.02% 8.87% 3.50%
0.03% 0.03% 0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
8.33% 9.75% 10.18% 10.18% 10.18% 15.91% 17.11% 17.50% 17.50% 17.96% 25.12% 30.49%
No. of Shareholders 4,7304,8595,1235,0475,0455,2066,5867,8638,5299,99413,73714,620

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Nov 2025
    Transcript
    AI Summary
    PPT
  • Aug 2025
    Transcript
    AI Summary
    PPT
  • Jun 2025
    Transcript
    AI Summary
    PPT
  • Feb 2025
    Transcript
    AI Summary
    PPT
  • Nov 2024
    Transcript
    AI Summary
    PPT
  • Aug 2024
    Transcript
    AI Summary
    PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • Feb 2024
    Transcript
    AI Summary
    PPT
  • Nov 2023
    Transcript
    AI Summary
    PPT
  • Aug 2023
    Transcript
    AI Summary
    PPT
  • May 2023
    Transcript
    AI Summary
    PPT
  • Feb 2023
    Transcript
    AI Summary
    PPT
  • Jan 2023
    Transcript
    AI Summary
    PPT
  • Nov 2022
    Transcript
    PPT
  • Nov 2022
    Transcript PPT
  • Oct 2022
    Transcript
    AI Summary
    PPT
  • Aug 2022
    Transcript
    PPT
  • Aug 2022
    Transcript PPT
  • Aug 2022
    Transcript
    AI Summary
    PPT
  • Jun 2022
    Transcript
    AI Summary
    PPT
  • Jun 2022
    Transcript
    AI Summary
    PPT
  • Feb 2022
    Transcript
    AI Summary
    PPT
  • Nov 2021
    Transcript
    AI Summary
    PPT
  • Jul 2021
    Transcript
    AI Summary
    PPT
  • May 2021
    Transcript
    AI Summary
    PPT
  • Feb 2021
    Transcript PPT
  • Oct 2020
    Transcript
    AI Summary
    PPT